Copyright Reports & Markets. All rights reserved.

Global Liquid Embolic Agent Market Growth 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Liquid Embolic Agent Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Liquid Embolic Agent by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Liquid Embolic Agent by Country/Region, 2017, 2022 & 2028
  • 2.2 Liquid Embolic Agent Segment by Type
    • 2.2.1 6% EVOH
    • 2.2.2 8% EVOH
  • 2.3 Liquid Embolic Agent Sales by Type
    • 2.3.1 Global Liquid Embolic Agent Sales Market Share by Type (2017-2022)
    • 2.3.2 Global Liquid Embolic Agent Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global Liquid Embolic Agent Sale Price by Type (2017-2022)
  • 2.4 Liquid Embolic Agent Segment by Application
    • 2.4.1 Arteriovenous Malformations
    • 2.4.2 Hypervascular Tumors
    • 2.4.3 Other
  • 2.5 Liquid Embolic Agent Sales by Application
    • 2.5.1 Global Liquid Embolic Agent Sale Market Share by Application (2017-2022)
    • 2.5.2 Global Liquid Embolic Agent Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global Liquid Embolic Agent Sale Price by Application (2017-2022)

3 Global Liquid Embolic Agent by Company

  • 3.1 Global Liquid Embolic Agent Breakdown Data by Company
    • 3.1.1 Global Liquid Embolic Agent Annual Sales by Company (2020-2022)
    • 3.1.2 Global Liquid Embolic Agent Sales Market Share by Company (2020-2022)
  • 3.2 Global Liquid Embolic Agent Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Liquid Embolic Agent Revenue by Company (2020-2022)
    • 3.2.2 Global Liquid Embolic Agent Revenue Market Share by Company (2020-2022)
  • 3.3 Global Liquid Embolic Agent Sale Price by Company
  • 3.4 Key Manufacturers Liquid Embolic Agent Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Liquid Embolic Agent Product Location Distribution
    • 3.4.2 Players Liquid Embolic Agent Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Liquid Embolic Agent by Geographic Region

  • 4.1 World Historic Liquid Embolic Agent Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Liquid Embolic Agent Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Liquid Embolic Agent Annual Revenue by Geographic Region
  • 4.2 World Historic Liquid Embolic Agent Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Liquid Embolic Agent Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Liquid Embolic Agent Annual Revenue by Country/Region
  • 4.3 Americas Liquid Embolic Agent Sales Growth
  • 4.4 APAC Liquid Embolic Agent Sales Growth
  • 4.5 Europe Liquid Embolic Agent Sales Growth
  • 4.6 Middle East & Africa Liquid Embolic Agent Sales Growth

5 Americas

  • 5.1 Americas Liquid Embolic Agent Sales by Country
    • 5.1.1 Americas Liquid Embolic Agent Sales by Country (2017-2022)
    • 5.1.2 Americas Liquid Embolic Agent Revenue by Country (2017-2022)
  • 5.2 Americas Liquid Embolic Agent Sales by Type
  • 5.3 Americas Liquid Embolic Agent Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Liquid Embolic Agent Sales by Region
    • 6.1.1 APAC Liquid Embolic Agent Sales by Region (2017-2022)
    • 6.1.2 APAC Liquid Embolic Agent Revenue by Region (2017-2022)
  • 6.2 APAC Liquid Embolic Agent Sales by Type
  • 6.3 APAC Liquid Embolic Agent Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Liquid Embolic Agent by Country
    • 7.1.1 Europe Liquid Embolic Agent Sales by Country (2017-2022)
    • 7.1.2 Europe Liquid Embolic Agent Revenue by Country (2017-2022)
  • 7.2 Europe Liquid Embolic Agent Sales by Type
  • 7.3 Europe Liquid Embolic Agent Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Liquid Embolic Agent by Country
    • 8.1.1 Middle East & Africa Liquid Embolic Agent Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Liquid Embolic Agent Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Liquid Embolic Agent Sales by Type
  • 8.3 Middle East & Africa Liquid Embolic Agent Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Liquid Embolic Agent
  • 10.3 Manufacturing Process Analysis of Liquid Embolic Agent
  • 10.4 Industry Chain Structure of Liquid Embolic Agent

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Liquid Embolic Agent Distributors
  • 11.3 Liquid Embolic Agent Customer

12 World Forecast Review for Liquid Embolic Agent by Geographic Region

  • 12.1 Global Liquid Embolic Agent Market Size Forecast by Region
    • 12.1.1 Global Liquid Embolic Agent Forecast by Region (2023-2028)
    • 12.1.2 Global Liquid Embolic Agent Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Liquid Embolic Agent Forecast by Type
  • 12.7 Global Liquid Embolic Agent Forecast by Application

13 Key Players Analysis

  • 13.1 Medtronic
    • 13.1.1 Medtronic Company Information
    • 13.1.2 Medtronic Liquid Embolic Agent Product Offered
    • 13.1.3 Medtronic Liquid Embolic Agent Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Medtronic Main Business Overview
    • 13.1.5 Medtronic Latest Developments
  • 13.2 Terumo
    • 13.2.1 Terumo Company Information
    • 13.2.2 Terumo Liquid Embolic Agent Product Offered
    • 13.2.3 Terumo Liquid Embolic Agent Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 Terumo Main Business Overview
    • 13.2.5 Terumo Latest Developments
  • 13.3 Balt
    • 13.3.1 Balt Company Information
    • 13.3.2 Balt Liquid Embolic Agent Product Offered
    • 13.3.3 Balt Liquid Embolic Agent Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Balt Main Business Overview
    • 13.3.5 Balt Latest Developments
  • 13.4 MicroVention
    • 13.4.1 MicroVention Company Information
    • 13.4.2 MicroVention Liquid Embolic Agent Product Offered
    • 13.4.3 MicroVention Liquid Embolic Agent Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 MicroVention Main Business Overview
    • 13.4.5 MicroVention Latest Developments
  • 13.5 CERENOVUS
    • 13.5.1 CERENOVUS Company Information
    • 13.5.2 CERENOVUS Liquid Embolic Agent Product Offered
    • 13.5.3 CERENOVUS Liquid Embolic Agent Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 CERENOVUS Main Business Overview
    • 13.5.5 CERENOVUS Latest Developments
  • 13.6 Meril Life
    • 13.6.1 Meril Life Company Information
    • 13.6.2 Meril Life Liquid Embolic Agent Product Offered
    • 13.6.3 Meril Life Liquid Embolic Agent Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 Meril Life Main Business Overview
    • 13.6.5 Meril Life Latest Developments
  • 13.7 Saikesaisi Holding
    • 13.7.1 Saikesaisi Holding Company Information
    • 13.7.2 Saikesaisi Holding Liquid Embolic Agent Product Offered
    • 13.7.3 Saikesaisi Holding Liquid Embolic Agent Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 Saikesaisi Holding Main Business Overview
    • 13.7.5 Saikesaisi Holding Latest Developments

14 Research Findings and Conclusion

As the global economy mends, the 2021 growth of Liquid Embolic Agent will have significant change from previous year. According to our (LP Information) latest study, the global Liquid Embolic Agent market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Liquid Embolic Agent market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Liquid Embolic Agent market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Liquid Embolic Agent market, reaching US$ million by the year 2028. As for the Europe Liquid Embolic Agent landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Liquid Embolic Agent players cover Medtronic, Terumo, Balt, and MicroVention, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Liquid Embolic Agent market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
6% EVOH
8% EVOH

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Arteriovenous Malformations
Hypervascular Tumors
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Medtronic
Terumo
Balt
MicroVention
CERENOVUS
Meril Life
Saikesaisi Holding
Buy now